Mutations of the SYNGAP1 gene were first identified in 2009 in patients with intellectual disability (ID) and autism spectrum disorder (ASD), followed in 2013 by recognition of their important role in the developmental and epileptic encephalopathies (DEEs) [26]. This evidence concerns the gene SYNGAP1 and Intellectual disability.